lycorine has been researched along with Breast Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, JF; Shi, L; Zhai, J | 1 |
Gao, X; Gu, Y; Jin, X; Sethi, G; Sharopov, FS; Sun, Y; Wink, M; Yang, L | 1 |
Wang, J; Xing, G; Xu, J | 1 |
He, P; Huang, A; Lan, L; Xing, Y; Yi, Z; Ying, X | 1 |
4 other study(ies) available for lycorine and Breast Neoplasms
Article | Year |
---|---|
Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Tamoxifen; Transcription Factors | 2023 |
Lycorine suppresses the malignancy of breast carcinoma by modulating epithelial mesenchymal transition and β-catenin signaling.
Topics: beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Wnt Signaling Pathway | 2023 |
Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Mice, Nude; Neoplasm Metastasis; Phenanthridines; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Phenanthridines; Signal Transduction; src-Family Kinases; Xenograft Model Antitumor Assays | 2017 |